Hillsdale Investment Management Inc. Takes $4.67 Million Position in InfuSystem Holdings, Inc. $INFU

Hillsdale Investment Management Inc. bought a new position in shares of InfuSystem Holdings, Inc. (NYSE:INFUFree Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 450,273 shares of the company’s stock, valued at approximately $4,665,000. Hillsdale Investment Management Inc. owned 2.21% of InfuSystem at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. CWM LLC grew its holdings in InfuSystem by 1,160.1% in the second quarter. CWM LLC now owns 4,826 shares of the company’s stock worth $30,000 after purchasing an additional 4,443 shares during the period. Raymond James Financial Inc. bought a new position in shares of InfuSystem in the second quarter valued at approximately $33,000. ARS Investment Partners LLC bought a new stake in InfuSystem during the third quarter worth $117,000. JPMorgan Chase & Co. boosted its holdings in InfuSystem by 961.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 16,799 shares of the company’s stock worth $174,000 after acquiring an additional 15,217 shares during the last quarter. Finally, Jane Street Group LLC purchased a new position in InfuSystem during the first quarter worth about $96,000. Institutional investors own 71.13% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Roth Mkm reissued a “buy” rating and issued a $14.00 price target (up from $13.00) on shares of InfuSystem in a report on Tuesday, November 4th. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $14.50.

Get Our Latest Stock Report on INFU

InfuSystem Stock Up 0.6%

INFU stock opened at $7.95 on Friday. InfuSystem Holdings, Inc. has a 1-year low of $4.61 and a 1-year high of $11.04. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The stock has a market cap of $161.67 million, a price-to-earnings ratio of 132.52 and a beta of 1.67. The company’s 50 day moving average is $8.49 and its 200 day moving average is $9.31.

About InfuSystem

(Free Report)

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.

Read More

Want to see what other hedge funds are holding INFU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InfuSystem Holdings, Inc. (NYSE:INFUFree Report).

Institutional Ownership by Quarter for InfuSystem (NYSE:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.